Status:
RECRUITING
Diabetes Electronic Prompt for Improved Care Coordination and Treatment in the ED
Lead Sponsor:
Rutgers, The State University of New Jersey
Conditions:
Type 2 Diabetes
Type 2 Diabetes Mellitus (T2DM)
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
The goal of this clinical trial is to improve the processes of Type 2 Diabetes (T2D) care coordination and treatment in the emergency department (ED) by utilizing clinical decision support mechanisms ...
Detailed Description
Type 2 Diabetes (T2D) is a growing public health crisis with rates of diabetes steadily increasing over the last 10 years. The ED is commonly the first point of contact for individuals who present wit...
Eligibility Criteria
Inclusion
- Moderate hyperglycemia, (glucose ≥250 mg/dL)
- Patients who arrive in the emergency department
- Not pregnant or peri-partum
- Not SARS-COV-2 PCR positive in past 7 days
Exclusion
- Diabetic ketoacidosis (pH \< 7.20, HCO3 \< 15, AG \> 25)
- Diabetic foot ulcer or skin complications
- Hyperglycemic hyperosmolar state with neurologic impairment
- Patients who leave against medical advice (AMA), elope from the ED, or are transferred to another facility
Key Trial Info
Start Date :
March 30 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2026
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06899191
Start Date
March 30 2025
End Date
March 1 2026
Last Update
May 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rutgers, Robert Wood Johnson Hospital
New Brunswick, New Jersey, United States, 08901